The Role of Aldosterone in OSA and OSA-Related Hypertension

Obstructive sleep apnea (OSA) is regarded as an independent risk factor for hypertension. The possible mechanism includes oxidative stress, endothelial injury, sympathetic excitement, renin-angiotensin-aldosterone system activation, etc. Clinical studies have found that there is a high coexistence of OSA and primary aldosteronism in patients with hypertension and that elevated aldosterone levels are independently associated with OSA severity in resistant hypertension. The underlying mechanism is that aldosterone excess can exacerbate OSA through increasing overnight fluid shift and affecting the mass and function of upper airway muscles during the sleep period. Thus, a bidirectional influence between OSA and aldosterone exists and contributes to hypertension in OSA patients, especially resistant hypertension.

Automated summary

Obstructive sleep apnea (OSA) is an independent risk factor for hypertension, and the underlying mechanisms include oxidative stress, endothelial injury, sympathetic excitement, and renin-angiotensin-aldosterone system activation. Clinical studies have shown a high coexistence of OSA and primary aldosteronism in hypertensive patients, and elevated aldosterone levels are independently associated with OSA severity in resistant hypertension.